Acquiring Company
RF Acquisition II
Acquired Company
Nanyang Biologics Pte. Ltd
Description
On October 2, 2025, RF Acquisition Corp II entered into a Business Combination Agreement with Nanyang Biologics Pte. Ltd., resulting in Nanyang becoming a wholly-owned subsidiary of PubCo. This merger aims to strengthen RF Acquisition's position in the deep technology sector. The agreement outlines a comprehensive amalgamation process. The completion of the Business Combination is critical for the company's operational future.
Quick answer
RF Acquisition II is acquiring Nanyang Biologics Pte. Ltd, announced November 6, 2025. RF Acquisition II is based in United States.
- How much did RF Acquisition II pay for Nanyang Biologics Pte. Ltd?
- The deal value was not disclosed.
- What does RF Acquisition II do?
- RF Acquisition Corp II is a Cayman Islands-based special purpose acquisition company (SPAC) focused on identifying and merging with high-growth companies across various industries.
- Where are RF Acquisition II and Nanyang Biologics Pte. Ltd based?
- RF Acquisition II is based in United States. Nanyang Biologics Pte. Ltd is based in Singapore.
Source: Fundz verified event record.
Other recent acquisitions in Software and Artificial Intelligence
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nvidia acquires SchedMD to enhance open source AI (December 15, 2025)
- Acumant acquires Northprim for Nordic expansion (December 19, 2025)
- Ateko acquires SDK Tek to enhance AI capabilities (December 18, 2025)
- Automation Anywhere Acquires Aisera for AI Growth (November 4, 2025)
- Perplexity AI acquires Visual Electric for growth (October 4, 2025)
- RF Acquisition Corp II to acquire Nanyang Biologics (October 2, 2025)
Who to call at RF Acquisition II, and when
When RF Acquisition II changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day RF Acquisition II raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RF Acquisition II, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RF Acquisition II. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RF Acquisition II makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Nanyang Biologics Pte. Ltd?
Nanyang Biologics Pte. Ltd was acquired by RF Acquisition II, based in United States. The deal was reported on November 6, 2025. RF Acquisition Corp II is a Cayman Islands-based special purpose acquisition company (SPAC) focused on identifying and merging with high-growth companies across various industries. RF Acquisition II is publicly traded (RFAI) and operates in Software.
When did RF Acquisition II acquire Nanyang Biologics Pte. Ltd?
RF Acquisition II's acquisition of Nanyang Biologics Pte. Ltd was reported on November 6, 2025. On October 2, 2025, RF Acquisition Corp II entered into a Business Combination Agreement with Nanyang Biologics Pte. Ltd., resulting in Nanyang becoming a wholly-owned subsidiary of PubCo. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nanyang Biologics Pte. Ltd do?
Nanyang Biologics Pte. Ltd. is an AI-driven drug discovery and biotechnology company known for its Vecura™ AI platform. The company focuses on developing innovative drug candidates by leveraging artificial intelligence and extensive research. It is privately held, operating in Biotechnology, and is based in Singapore.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.